Search for Clinical Trial Results

Sponsored By

Cholangitis, Sclerosing - 8 Studies Found

Status Study
Completed Study Name: Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis
Condition: Cholangitis, Sclerosing
Date: 2000-02-24
Interventions: Drug: cladribine
Completed Study Name: Probiotics in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2005-09-08
Interventions: Drug: Probiotics
Active, not recruiting Study Name: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
Condition: Primary Sclerosing Cholangitis
Date: 2013-02-21
Interventions: Drug: Oral Vancomycin Other Name: Vancocin
Recruiting Study Name: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
Condition: Primary Sclerosing Cholangitis
Date: 2015-10-31
Interventions:
  • Drug: Vancomycin Vancomycin fo
Completed Study Name: A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2010-03-10
Interventions:
  • Drug: Vancomycin Comparison of
Recruiting Study Name: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2016-11-22
Interventions: Drug: Curcumin Subjects will receive one 750 mg softgel by mouth twice a day for 12 weeks. Each each 750
Completed Study Name: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2012-12-19
Interventions:
  • Drug: norUDCA Comparison of di
Active, not recruiting Study Name: Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2016-02-29
Interventions:
  • Biological: NGM282
  • Other: Placebo